Work

Secondary primary lymphoma (SPL) following immune checkpoint inhibitor (ICI) therapy: FDA Adverse Event Reporting System (FAERS) review.

Year: 2025

Type: conference-abstract

Source: JCO Oncology Practice

DOI: 10.1200/op.2025.21.10_suppl.436

Authors: Youngjoo Kim, Sekwon Jang

Institution: Inova Fairfax Hospital

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4414913382

Cites:

Cited by:

Related to: